ALDER BIOPHARMACEUTICALS INC (ALDR) analyst actions
Rating and price-target actions on ALDR in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ALDR overview →
No ALDR analyst action events in the measured window.
Nothing matched in the current window — the ALDR overview has every event we measure for this name.
Get an email when ALDR moves on news →Keep exploring
More ALDR: earnings → · SEC filings → · ALDR overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
| REGENXBIO Inc. (RGNX) | 696 | +0.35% | 54% |
| DIGIRAD (DRAD) | 692 | 0.00% | 39% |
| Teva Pharmaceutical Industries Limited (TEVA) | 692 | -0.06% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.